Characterization of chemical ingredients and anticonvulsant activity of American skullcap (Scutellaria lateriflora)

Phytomedicine

Volumn 16, Issue 5, 2009, Pages 485-493

  Zhang, Zhizhen ^a   Lian, Xiao yuan ^b,c   Li, Shiyou ^a   Stringer, Janet L ^b  

^a STEPHEN F AUSTIN STATE UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

American skullcap; Anticonvulsant activity; Flavonoids; HPLC; Phenylethanoid glycosides; Scutellaria lateriflora

Indexed keywords

AMERICAN SKULLCAP EXTRACT; HERBACEOUS AGENT; PENTETRAZOLE; PILOCARPINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; RAT; SCUTELLARIA LATERIFLOR; SEIZURE;

ANIMALS; ANTICONVULSANTS; FLAVONOIDS; GLUCOSIDES; MALE; PHENOLS; PHENYLETHYL ALCOHOL; PHYTOTHERAPY; PILOCARPINE; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SCUTELLARIA; SEIZURES;

RATTUS; RODENTIA; SCUTELLARIA; SCUTELLARIA LATERIFLORA;

EID: 64449089042     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.07.011     Document Type: Article

References (37)

1. Ahn H.C., Lee S.Y., Kim J.W., Son W.S., Shin C.G., and Lee B.J. Binding aspects of baicalein to HIV-1 integrase. Mol. Cells 12 (2001) 127-130
2. Awad R., Arnason J.T., Trudeau V., Bergeron C., Budzinski J.W., Foster B.C., and Merali Z. Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine 10 (2003) 640-649
3. Bergeron C., Gafner S., Clausen E., and Carrier D.J. Comparison of the chemical composition of extracts from Scutellaria lateriflora using accelerated solvent extraction and supercritical fluid extraction versus standard hot water or 70% ethanol extraction. J. Agric. Food Chem. 53 (2005) 3076-3080
4. Bough K.J., Gudi K., Han F.T., Rathod A.H., and Eagles D.A. An anticonvulsant profile of the ketogenic diet in the rat. Epilepsy Res. 50 (2002) 313-325
5. Bruno M., Cruciata M., Bondi M.L., Piozzi F., De la Torre M.C., Rodriguez B., and Servettaz O. Neoclerodane diterpenoids from Scutellaria lateriflora L. Phytochemistry 48 (1998) 687-691
6. Chen L.J., Games D.E., and Jones J. Isolation and identification of four flavonoid constituents from the seeds of Oroxylum indicum by high-speed counter-current chromatography. J. Chromatogr. A 988 (2003) 95-105
7. Cho J., and Lee H.K. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells. Eur. J. Pharmacol. 485 (2004) 105-110
8. Editorial Committee of Chinese Herbal. Chinese Herbal vol. 7 (1999), Shanghai Science and Technology Press, Shanghai, China pp. 200-210
9. 3H]-LSD binding to 5-HT7 receptors by flavonoids from Scutellaria lateriflora. J. Nat. Prod. 66 (2003) 535-537
10. Gao J., Sanchez-Medina A., Pendry B.A., Hughes M.J., Webb G.P., and Corcoran O. Validation of a HPLC method for flavonoid biomarkers in skullcap (Scutellaria) and its use to illustrate wide variability in the quality of commercial tinctures. J. Pharm. Pharm. Sci. 11 (2008) 77-87
11. Hahm D.H., Yeom M.J., Lee E.H., Shim I., Lee H.J., and Kim H.Y. Effect of Scutellariae radix as a novel antibacterial herb on the ppk (polyphosphate kinase) mutant of Salmonella typhimurium. J. Microbiol. Biotechnol. 11 (2001) 1061-1065
12. Huang W.H., Lee A.R., and Yang C.H. Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Biosci. Biotechnol. Biochem. 70 (2006) 2371-2380
13. Kikuchi Y., Miyaichi Y., Yamaguchi Y., Kizu H., Tomimori T., and Vetschera K. Studies on the constituents of Scutellaria species. XIV. On the constituents of the roots and the leaves of Scutellaria alpina L. Chem. Pharm. Bull. 39 (1991) 199-201
14. Lee H., Kim Y.O., Kim H., Kim S.Y., Noh H.S., Kang S.S., Cho G.J., Choi W.S., and Suk K. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 17 (2003) 1943-1964
15. Lian X.Y., Zhang Z.Z., and String J.L. Anticonvulsant activity of ginseng on seizures induced by chemical convulsants. Epilepsia 46 (2005) 15-22
16. Liao J.F., Hung W.Y., and Chen C.F. Anxiolytic effects of baicalein and baicalin in the Vogel conflict test in mice. Eur. J. Pharmacol. 464 (2003) 141-146
17. Lipton S.A., and Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330 (1994) 613-622
18. Liu L.Y., Wei E.Q., Zhao Y.M., Chen F.X., Wang M.L., Zhang W.P., and Chen Z. Protective effects of baicalin on oxygen/glucose deprivation- and NMDA-induced injuries in rat hippocampal slices. J. Pharm. Pharmacol. 57 (2005) 1019-1026
19. Liu Y.L., Song W.Z., Ji Q.Y., and Bai Y.L. The structure of ganhuangenin, a new flavonoid from the root of Gansuhuangqin (Scutellaria rehderiana). Acta Pharmacol. Sin. 19 (1984) 830-835
20. Makino T., Hishida A., Goda Y., and Mizukami H. Comparison of the major flavonoid content of S. baicalensis, S. lateriflora, and their commercial products. J. Nat. Med. (2008) 10.1007/s11418-008-0230-7
21. Millspaugh C.F. American Medicinal Plants (1974), Dover Publications, New York pp. 469-472
22. Numata A., Pettit G.R., Nabae M., Yamamoto K., Yamamoto E., Matsumara E., and Kawano T. Assignment of quaternary carbons in aromatic compounds by long-range heteronuclear shift correlated 2D-NMR spectroscopy and its application to acteoside. Agric. Biol. Chem. 51 (1987) 1199-1201
23. Park H.G., Yoon S.Y., Choi J.Y., Lee G.S., Choi J.H., Shin C.Y., Son K.H., Lee Y.S., Kim W.K., Ryu J.H., Ko K.H., and Cheong J.H. Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur. J. Pharmacol. 574 (2007) 112-119
24. Patel M.N. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radical Biol. Med. 37 (2004) 1951-1962
25. Sasaki H., Taguchi H., Endo T., Tosioka I., Higashiyama K., and Otomasu H. The glycosides of martynia louisiana Mill. A new phenylpropanoid glycoside, martynoside. Chem. Pharm. Bull. 26 (1978) 2111-2121
26. Schwartz R.D., Yu X., Katzman M.R., Hayden-Hixson D.M., and Perry J.M. Diazepam, given postischemia, protests selectively vulnerable neurons in the rat hippocampus and striatum. J. Neurosci. 15 (1995) 529-539
27. Shen C.C., Chang Y.S., and Hott L.K. Nuclear magnetic resonance studies of 5,7-dihydroxyflavonoids. Phytochemistry 34 (1993) 843-845
28. Takagi S., Yamaki M., and Inoue K. Flavone di-C-glycosides from Scutellaria baicalensis. Phytochemistry 20 (1981) 2443-2444
29. Vezzani A., and Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46 (2005) 1724-1743
30. A receptor complex. Planta Med. 68 (2002) 1059-1062
31. Wolfson P., and Hoffmann D.L. An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern. Ther. Health Med. 9 (2003) 74-78
32. Wu S., Sun A., and Liu R. Separation and purification of baicalin and wogonoside from the Chinese medicinal plant Scutellaria baicalensis Georgi by high-speed counter-current chromatography. J. Chromatogr. A 1066 (2005) 243-247
33. A receptor-mediated mechanisms. Ann. Neurol. 59 (2006) 42-52
34. Xiao L.H., Wang H.Y., Song S.J., Zhang G.P., Song H.X., and Xu S.X. Isolation and identification of the chemical constituents of roots of Scutellaria amoena C.H. Wright. Shenyang Yaoke Daxue Xuebao 20 (2003) 181-183
35. Yaghmai M.S. Volatile constituents of Scutellaria lateriflora L. Flav. Frag. J. 3 (1988) 27-31
36. Zhang D.Y., Wu J., Ye F., Xue L., Jiang S., Yi J., Zhang W., Wei H.C., Sung M., Wang W., and Li X. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res. 63 (2003) 4037-4043
37. Zhang Y.Y., Gou Y.Z., Onda M., Hashimoto K., Ikeya Y., Okada M., and Maruno M. Four flavonoids from Scutellaria baicalensis. Phytochemistry 35 (1994) 511-514